Shire's Citizen Petitions Too Old For FTC Action; Door Left Open For Amended Suit

 Court tosses FTC complaint alleging Shire used the citizen petition process to maintain a monopoly on Vancocin, says agency did not show company was 'about to violate' the law.

court house

Timing was a decisive factor in the Federal Trade Commission's suit against Shire PLC subsidiary Shire ViroPharama Inc. over its filing of 24 citizen petitions, as a court found that the agency had not shown Shire was "about to violate" a law and dismissed the complaint.

The agency filed suit against Shire in February 2017 alleging the company's use of FDA's citizen petition process constituted unfair...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership